Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Paresh Vyas is a clinical academic and Deputy Director of the MRC Molecular Haematology Unit (MHU), Weatherall Institute of Molecular Medicine (WIMM) at the University of Oxford. He is clinical lead for AML (Acute Myeloid Leukaemia) and MDS (Myelodysplasia) for Oxford and leads Phase I-III clinical trials in the UK and international in AMl and MDS. His research focuses on allo-immune responses to leukemia and the molecular and cellular biology of normal and leukaemic haemopoiesis.
